Kailos Genetics' Convertible Note Round

Kailos Genetics raised a round of funding on April 17, 2018.

Kailos Genetics helps predict individual patient response to drugs, enabling healthcare providers to identify responders and non-responders to potential drug therapy, avoid adverse drug reactions, and…

Articles about Kailos Genetics' Convertible Note Round: